Romeo Maciuca
- Effects of anti-M1 prime monoclonal antibody, MEMP1972A following allergen challenge in patients with mild asthmaBy Gail Gauvreau, Louis-Philippe Boulet, Donald Cockcroft, Beth Davis, Mark Fitzgerald, Richard Leigh, Barbro Dahlen, Irvin Mayers, Heleen Scheerens, Romeo Maciuca, John Matthews, Jeffrey Harris and Paul O'ByrneGail Gauvreau1Department of Medicine, McMaster University, Ontario, CanadaLouis-Philippe Boulet2Department of Pneumology, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Hôpital Laval, Quebec, CanadaDonald Cockcroft3Department of Medicine, University of Saskatchewan, Saskatoon, CanadaBeth Davis3Department of Medicine, University of Saskatchewan, Saskatoon, CanadaMark Fitzgerald4Department of Medicine, University of British Columbia, Vancouver, BC, CanadaRichard Leigh5Department of Medicine, University of Calgary, AB, CanadaBarbro Dahlen6Department of Medicine, Karolinska Institute, Stockholm, SwedenIrvin Mayers7Department of Medicine, University of Alberta, AB, CanadaHeleen Scheerens8PD Biomarkers, Genentech, Inc, South San Francisco, United StatesRomeo Maciuca9Biostatistics, Genetech, Inc, South San Francisco, United StatesJohn Matthews10Product Development - Immunology, Genentech, Inc, South San Francisco, United StatesJeffrey Harris11Research and Early Development, Genentech, Inc, South San Francisco, United StatesPaul O'Byrne1Department of Medicine, McMaster University, Ontario, Canada
- MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjectsBy Heleen Scheerens, Wendy Putnam, Yanan Zheng, Yehong Wang, Sofia Mosesova, Romeo Maciuca, Charlene Liao, Lawren Wu, John Matthews and Jeffrey HarrisHeleen Scheerens1PD Biomarkers, Genentech, Inc, South San Francisco, CA, United StatesWendy Putnam2Clinical Pharmacology, Genentech, Inc, South San Francisco, CA, United StatesYanan Zheng2Clinical Pharmacology, Genentech, Inc, South San Francisco, CA, United StatesYehong Wang2Clinical Pharmacology, Genentech, Inc, South San Francisco, CA, United StatesSofia Mosesova3Inflammation & Opthalmology Biostatistics, Genentech, Inc, South San Francisco, CA, United StatesRomeo Maciuca4Biostatistics, Genentech, Inc, South San Francisco, CA, United StatesCharlene Liao5Research and Early Development, Genentech, Inc, South San Francisco, CA, United StatesLawren Wu7Department of Immunology, Genentech, Inc, South San Francisco, CA, United StatesJohn Matthews6Product Development - Immunology, Genentech, Inc, South San Francisco, CA, United StatesJeffrey Harris5Research and Early Development, Genentech, Inc, South San Francisco, CA, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.